Drug combo doesn’t stem VWD postpartum bleeding, trial finds
Adding Cyklokapron (tranexamic acid) to Vonvendi (recombinant von Willebrand factor) does not appear to reduce blood loss following childbirth for women with von Willebrand…
Von Willebrand disease
Von Willebrand disease overview
Von Willebrand disease is a genetic bleeding disorder that impairs the body’s ability to form proper blood clots. It can cause frequent or prolonged bleeding episodes, but many people experience only mild or manageable symptoms.
Read more
Von Willebrand disease treatment options
Treatment for von Willebrand disease focuses on preventing and controlling bleeding to improve daily life and reduce serious risks. Management plans vary by disease type and may involve ongoing monitoring and personalized care strategies.
Read moreLatest news
FDA expands Vonvendi approval to cover more VWD patients
The U.S. Food and Drug Administration (FDA) has expanded its approval of Vonvendi (recombinant von Willebrand factor), a treatment for von Willebrand disease (VWD).